サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1309032

インターベンショナル腫瘍学市場：手技別、がんタイプ別、エンドユーザー別-2023-2030年の世界予測

Interventional Oncology Market by Procedure, Cancer Type, End-Users - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 181 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
インターベンショナル腫瘍学市場：手技別、がんタイプ別、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

インターベンショナル腫瘍学の世界市場は、2023年に50億4,336万米ドル、CAGR7.84％で大きく成長し、2030年には85億6,682万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のインターベンショナル腫瘍学市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.インターベンショナル腫瘍学の世界市場規模および予測は？

2.予測期間中、世界のインターベンショナル腫瘍学市場を形成するCOVID-19の阻害要因と影響は？

3.インターベンショナル腫瘍学の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.インターベンショナル腫瘍学の世界市場における競争戦略は？

5.インターベンショナル腫瘍学の世界市場における技術動向と規制の枠組みは？

6.インターベンショナル腫瘍学の世界市場における主要ベンダーの市場シェアは？

7.インターベンショナル腫瘍学の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中でがんの発生率が上昇し、高齢者人口が急増
      • インターベンショナル腫瘍学に対する政府支出の増加
      • 低侵襲処置を好む
    • 抑制要因
      • 訓練を受けた腫瘍介入医の不足
    • 機会
      • 外来患者設定でインターベンショナル腫瘍学を提供する利点
      • インターベンショナル腫瘍学の新たな技術の進歩
    • 課題
      • 代替療法の存在
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 インターベンショナル腫瘍学市場手順別

  • アブレーション
  • 粒子塞栓術
  • 放射線治療

第7章 インターベンショナル腫瘍学市場がんの種類別

  • 骨転移
  • 乳がん
  • 腎臓がん
  • 肝臓がん
  • 肺がん
  • 前立腺がん

第8章 インターベンショナル腫瘍学市場：エンドユーザー別

  • 外来手術センター
  • 病院
  • 調査および学術機関

第9章 南北アメリカのインターベンショナル腫瘍学市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のインターベンショナル腫瘍学市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのインターベンショナル腫瘍学市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. INTERVENTIONAL ONCOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2022 VS 2030 (%)
  • FIGURE 5. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2022 VS 2030 (%)
  • FIGURE 6. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2022 VS 2030 (%)
  • FIGURE 7. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. INTERVENTIONAL ONCOLOGY MARKET DYNAMICS
  • FIGURE 9. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. INTERVENTIONAL ONCOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 5. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PARTICLE EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 16. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 146. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 147. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 148. INTERVENTIONAL ONCOLOGY MARKET LICENSE & PRICING
目次
Product Code: MRR-43127F7279CF

The Global Interventional Oncology Market is forecasted to grow significantly, with a projected USD 5,043.36 million in 2023 at a CAGR of 7.84% and expected to reach a staggering USD 8,566.82 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Interventional Oncology Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Interventional Oncology Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Procedure, market is studied across Ablation, Particle Embolization, and Radiation Therapy. The Particle Embolization is projected to witness significant market share during forecast period.

Based on Cancer Type, market is studied across Bone Metastasis, Breast Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, and Prostate Cancer. The Bone Metastasis is projected to witness significant market share during forecast period.

Based on End-Users, market is studied across Ambulatory Surgery Centers, Hospitals, and Research & Academic Institutes. The Ambulatory Surgery Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Interventional Oncology Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Interventional Oncology Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Interventional Oncology Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Interventional Oncology Market?

4. What is the competitive strategic window for opportunities in the Global Interventional Oncology Market?

5. What are the technology trends and regulatory frameworks in the Global Interventional Oncology Market?

6. What is the market share of the leading vendors in the Global Interventional Oncology Market?

7. What modes and strategic moves are considered suitable for entering the Global Interventional Oncology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Interventional Oncology Market, by Procedure, 2022 vs 2030
  • 4.3. Interventional Oncology Market, by Cancer Type, 2022 vs 2030
  • 4.4. Interventional Oncology Market, by End-Users, 2022 vs 2030
  • 4.5. Interventional Oncology Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in incidence of cancer across the globe and surge in geriatric population
      • 5.1.1.2. Increase in government expenditures for interventional oncology
      • 5.1.1.3. Preference for minimally invasive procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Shortage of trained interventional oncologists
    • 5.1.3. Opportunities
      • 5.1.3.1. Benefits of providing interventional oncology in an outpatient setting
      • 5.1.3.2. New technological advancements for interventional oncology
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of alternative therapies
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Interventional Oncology Market, by Procedure

  • 6.1. Introduction
  • 6.2. Ablation
  • 6.3. Particle Embolization
  • 6.4. Radiation Therapy

7. Interventional Oncology Market, by Cancer Type

  • 7.1. Introduction
  • 7.2. Bone Metastasis
  • 7.3. Breast Cancer
  • 7.4. Kidney Cancer
  • 7.5. Liver Cancer
  • 7.6. Lung Cancer
  • 7.7. Prostate Cancer

8. Interventional Oncology Market, by End-Users

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Hospitals
  • 8.4. Research & Academic Institutes

9. Americas Interventional Oncology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Interventional Oncology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Interventional Oncology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing